Tumor cell dynamics and metastasis in advanced neuroblastoma.
This study deals with the advancement process of neuroblastoma through clinical observations and circulating tumor cell exploration. Clinical feature, tumor biology, and circulating tumor cell detected by the previously described polymerase chain reaction (PCR) method were analyzed in 31 patients with advanced neuroblastoma treated in our department since 1991 through 2004. Treatment was completed in 28 patients, of whom 17 are alive without the disease and 11 died. The primary lesion was not confirmed in 2 patients with disseminated metastasis, both of whom showed positive circulating tumor cell. Circulating tumor cell was positive in 6 of 9 examined at their first appearance at the hospital, all had stage 4 disease, and 4 of the 6 (66.7%) died of systemic spread of the disease. N-myc was amplified in 15 patients, of whom only 2 (13.3%) died of systemic metastasis. N-myc amplification did not correlate with positive circulating tumor cell. A certain population of neuroblastoma may provide circulating tumor cells from the early period of the disease to form metastatic lesions independently of the primary lesion, which must be regulated by factors other than N-myc. Circulating tumor cells may suggest higher risk for systemic dissemination and poor prognosis.
Kuroda
Tatsuo
T
Department of Surgery, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. kuroda-t@ncchd.go.jp
Honna
Toshiro
T
Morikawa
Nobuyuki
N
Kitano
Yoshihiro
Y
Fuchimoto
Yasushi
Y
Terawaki
Kan
K
Kumagai
Masaaki
M
Tsunematsu
Yukiko
Y
Masaki
Hidekazu
H
Matsuoka
Kentaro
K
Saeki
Morihiro
M
D001859:Bone Neoplasms / Q000097:blood / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D016259:Genes, myc; D006801:Humans; D007223:Infant; D009362:Neoplasm Metastasis; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D009447:Neuroblastoma / Q000097:blood / Q000473:pathology*